Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Stockholders Equity of $14.33 million for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $14.33M | +142.6% |
| 2024 | -$33.65M | +0.9% |
| 2023 | -$33.97M | -350.3% |
| 2022 | $13.57M | -82.5% |
| 2021 | $77.57M | -67.2% |
| 2020 | $236.49M | -41.4% |
| 2019 | $403.83M | +9.1% |
| 2018 | $370.16M | +182.3% |
| 2017 | $131.14M | +717.1% |
| 2016 | -$21.25M | -118.0% |
| 2015 | $118.11M | +87.3% |
| 2014 | $63.06M | -8.5% |
| 2013 | $68.94M | +33.1% |
| 2012 | $51.82M | +229.0% |
| 2011 | $15.75M | +1097.0% |
| 2010 | $1.32M | -80.6% |
| 2009 | $6.80M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.88M | +137.2% | +154.6% |
| June 30, 2025 | -$27.26M | +28.2% | +4.2% |
| March 31, 2025 | -$28.45M | +15.7% | +15.4% |
| December 31, 2024 | -$33.65M | +0.9% | +15.9% |
| September 30, 2024 | -$40.01M | -44.0% | -5.4% |
| June 30, 2024 | -$37.94M | +3.4% | -12.4% |
| March 31, 2024 | -$33.77M | -195.4% | +0.6% |
| December 31, 2023 | -$33.97M | -350.3% | -22.3% |
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +142.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, HERON THERAPEUTICS, INC. /DE/’s stockholders equity has grown by 110.9% (from $6.80 million to $14.33 million).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: